Skip to main content
. 2021 Jan 27;43(6):e848–e853. doi: 10.1097/MPH.0000000000002068

FIGURE 2.

FIGURE 2

Kaplan-Meier estimates of 5-year relapse-free survival of the sacrococcygeal yolk sac tumor by pathologic response to neoadjuvant chemotherapy. The 5-year relapse-free survival rate of group good response (n=9) was significantly higher than that of group poor response (n=11) (P=0.026).